NTLAPharmaceuticals
FollowFollowingUnfollowFree · no card
Get what investors say about NTLA next
Follow NTLA free and new calls come to you in The Brief, our morning email, the day after we record them. This page shows them a week later.
or continue with Google ·
Who said what, and what NTLA did next
Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.
Who’s talking about NTLA
| Date | Voice | Stance | Venue | Thesis |
|---|---|---|---|---|
| 2026-01-23 | Cathie WoodCEO & CIO, ARK Invest | Bullish | ARK Invest | Intellia's in vivo CRISPR gene editing trial for HAE offers a one-time cure worth up to $11M in system… |
| 2024-10-17 | Cathie WoodCEO & CIO, ARK Invest | Bullish | RankiaPro | Intellia Therapeutics is a CRISPR-Cas9 gene-editing company in the most undervalued segment of markets… |
Next report: 5 Nov 2026
Notable options days
Sessions in the last 120 where NTLA’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-10-06 | ||||||
| 2026-09-17 | ||||||
| 2026-08-25 | ||||||
| 2026-08-19 | ||||||
| 2026-08-18 | ||||||
| 2026-07-16 | ||||||
| 2026-06-17 | ||||||
| 2026-06-16 | ||||||
| 2026-06-15 |
NTLA on the Wheel
NTLA is not in our put test yet; you can still add it to your Wheel and see its puts.
The Wheel lists cash-secured puts on stocks after a 3% drop, with live quotes, the chance of assignment and each stock’s own history. Free to use; a free account lets you follow stocks, add your own and ask questions.
Decision support, not advice · questions put sellers ask us
Idea Scout
Following NTLA? Every Sunday we read the tape so you don't have to — who's recommending what, where they agree, and who just changed their mind. One free email a week.
Free · double opt-in · unsubscribe in one click